Your browser doesn't support javascript.
loading
Rational Design of a Highly Sensitive Carboxylesterase Probe and Its Application in High-Throughput Screening for Uncovering Carboxylesterase Inhibitors.
Wang, Kexin; Wang, Ruoxi; Yan, Zihui; Li, Yi; Shi, Yangchen; Ge, Jing-Yuan; Bai, Yang; Chen, Zhongyan; Zhang, Lei.
Affiliation
  • Wang K; College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou 325035, P. R. China.
  • Wang R; College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou 325035, P. R. China.
  • Yan Z; School of Pharmacy, Changzhou University, Changzhou 213164, P. R. China.
  • Li Y; School of Pharmacy, Changzhou University, Changzhou 213164, P. R. China.
  • Shi Y; College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou 325035, P. R. China.
  • Ge JY; College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou 325035, P. R. China.
  • Bai Y; School of Pharmacy, Changzhou University, Changzhou 213164, P. R. China.
  • Chen Z; College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou 325035, P. R. China.
  • Zhang L; Key Lab of Biohealth Materials and Chemistry of Wenzhou, Wenzhou University, Wenzhou 325035, P. R. China.
J Org Chem ; 2024 May 08.
Article in En | MEDLINE | ID: mdl-38720168
ABSTRACT
Tracking carboxylesterases (CESs) through noninvasive and dynamic imaging is of great significance for diagnosing and treating CES-related metabolic diseases. Herein, three BODIPY-based fluorescent probes with a pyridine unit quaternarized via an acetoxybenzyl group were designed and synthesized to detect CESs based on the photoinduced electron transfer process. Notably, among these probes, BDPN2-CES exhibited a remarkable 182-fold fluorescence enhancement for CESs within 10 min. Moreover, BDPN2-CES successfully enabled real-time imaging of endogenous CES variations in living cells. Using BDPN2-CES, a visual high-throughput screening method for CES inhibitors was established, culminating in the discovery of an efficient inhibitor, WZU-13, sourced from a chemical library. These findings suggest that BDPN2-CES could provide a new avenue for diagnosing CES-related diseases, and WZU-13 emerges as a promising therapeutic candidate for CES-overexpression pathological processes.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Org Chem Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Org Chem Year: 2024 Document type: Article